Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Comparison of processing methods for 18F-florbetapir PET amyloid quantification

Frank DiFilippo, Sally Durgerian and Stephen Rao
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 454;
Frank DiFilippo
1Nuclear Medicine Cleveland Clinic Cleveland OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally Durgerian
2BrainDataDriven LLC Shorewood WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Rao
3Neurological Institute Cleveland Clinic Cleveland OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

454

Objectives: The IMMUNE-AD study (NIH R01-AG022304) is investigating potential mechanisms by which physical activity counteracts the negative effects of the APOE ε4 allele, a genetic risk factor for late onset Alzheimer’s disease. Among other parameters, the IMMUNE-AD study measures amyloid accumulation over a two-year period based on 18F-florbetapir PET scans. Although the Centiloid score has emerged as a standard measure of amyloid burden, alternate processing methods might provide higher precision and statistical power. To achieve this goal, we analyzed florbetapir PET images by different methods and compared statistics of ε4+ and ε4- cases.

Methods: 18F-florbetapir PET images were acquired and reconstructed under the ADNI3 protocol (4x5min frames, 50-70min post-injection) at a single site with a single scanner (Biograph mCT 4-ring). Participants are cognitively normal elders (65-80yrs), of which 18 ε4+ (ε3ε4) and 17 ε4- (ε3ε3) have had initial PET scans to date. Centiloid scores were computed using a Level-3-validated SPM8 pipeline (ref: Navitsky et al, 2018), which mapped 50-60min data (filtered 5mm Gaussian) to the MNI152 template and computed SUVR using standard Centiloid VOIs (cortex, referenced to whole cerebellum). In addition, cortical SUVR was computed from 50-70 min PET data using patient-specific VOIs in native space based on MRI T1 and FLAIR images. MRI segmentation was done in FreeSurfer v6 using the Human Connectome Project pipeline (-FLAIRpial and -no-conf2hires flags). PET analysis was done using PETSurfer in two ways: (1) “Standard” processing (filtered 5mm, co-registered summed images, without partial volume correction) and (2) “Enhanced” processing (unfiltered, frame-by-frame processing, with partial volume correction 5mm kernel). In both cases, SUVR was computed twice, using whole cerebellum (WC) or cerebellar gray matter (CGM) as reference. For consistency in comparisons, SUVR was rescaled to Centiloid units via linear regression to standard Centiloid scores.

Results: Normal PET studies (Centiloid<24: 14 ε4+ and 16 ε4- cases) were compared statistically (see Table). The normal ε4- cases are expected to be tightly clustered, and thus the standard deviation (SD) indicates the noise associated with PET analysis. Native-space processing had smaller SD than template-based Centiloid processing. Although CGM-reference had larger SD than WC-reference for both Centiloid and native-Standard processing, CGM-reference had the lowest overall SD for native-Enhanced processing. Next, the likelihood that the normal ε4+ and ε4- cases are distributed similarly was evaluated (Mann-Whitney test). The Centiloid and native-Standard results support this hypothesis. However, the native-Enhanced results reject it (p<0.05), indicating that the “normal” ε4+ cases have greater amyloid burden than the normal ε4- cases.

Conclusions: These results indicate that the precision of amyloid PET measurements is improved with Native-Enhanced processing, compared to standard Centiloid processing. Native-Enhanced processing appears to have greater ability to stratify cases with low amyloid levels. Further study is planned with dual-timepoint scans, when available, to evaluate longitudinal precision of these processing methods.

View this table:
  • View inline
  • View popup

Comparison of PET processing methods (SD in Centiloid units; p-value * <0.05)

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of processing methods for 18F-florbetapir PET amyloid quantification
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of processing methods for 18F-florbetapir PET amyloid quantification
Frank DiFilippo, Sally Durgerian, Stephen Rao
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 454;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of processing methods for 18F-florbetapir PET amyloid quantification
Frank DiFilippo, Sally Durgerian, Stephen Rao
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 454;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Design of calcium-sensing receptor targeted thera(g)nostic agents
  • Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
  • Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Novel Neuroimaging Approaches

  • Discovery of Subtype Selective Phosphodiesterase-4D (PDE4D) Ligands and Evaluation as Potential Radioligands for Brain Imaging in Monkey and Human
  • Early peak equilibrium is superior to late pseudo-equilibrium for simplified quantification of 18F-FE-PE2I PET
Show more Novel Neuroimaging Approaches

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire